Comparative outcomes of exposing human liver and kidney cell lines to tungstate and molybdate.


Journal

Toxicology mechanisms and methods
ISSN: 1537-6524
Titre abrégé: Toxicol Mech Methods
Pays: England
ID NLM: 101134521

Informations de publication

Date de publication:
Nov 2021
Historique:
pubmed: 30 7 2021
medline: 26 11 2021
entrez: 29 7 2021
Statut: ppublish

Résumé

Tungsten has no known function in humans and is a relatively new contaminant, whereas molybdenum, its congener in the periodic table, is a nutritionally essential element. In addition to early studies on molybdosis in ruminants, their toxic effects in the form of tungstate and molybdate have been addressed primarily in rodents and are predominantly mediated by inducing oxidative stress in various tissues. The purpose of this study was to evaluate the differences between tungstate and molybdate in human liver (HepG2) and kidney (HEK293) cell lines in terms of retention in cells, effect on reactive oxygen species, and activities of xanthine oxidase and phosphatases. The cell lines were exposed to tungstate or molybdate (1 µM to 10 mM) for 24 h, lysed and analyzed for the above biochemical parameters. Despite the chemical similarity of the two anions, cell-specific differential effects were observed. At all concentrations, tungstate was retained more in HEK293 cells while molybdate was retained more in HepG2 cells. HepG2 cells were more sensitive to tungstate than molybdate, showing reduced viability at concentrations as low as 10 µM. Exposure to either anion resulted in the inhibition of protein tyrosine phosphatases at 1 mM and an increased production of reactive oxygen species (ROS) at 100 µM despite their inhibition of the ROS-producing molybdenum enzyme xanthine oxidase. In conclusion, the results indicate that excess of nutritionally essential molybdate or non-essential tungstate causes toxicity by affecting ROS- and phosphorylation-dependent signaling pathways and ensuing gene expression.

Identifiants

pubmed: 34320920
doi: 10.1080/15376516.2021.1956031
doi:

Substances chimiques

Tungsten Compounds 0
molybdate 14259-85-9
Molybdenum 81AH48963U
tungstate SW0Y0WQ46I

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

690-698

Auteurs

Sherry Sachdeva (S)

Division of Regulatory Toxicology, Defence Research Development Establishment, Gwalior, India.

Wolfgang Maret (W)

Department of Nutritional Sciences, Faculty of Life Sciences and Medicine, School of Life Course Sciences, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH